Bill would exempt joint drug price negotiations
Citing pharmaceutical spending as nearly 20% of healthcare costs in the US, a congressman has proposed a safe harbour from antitrust liability for private health insurers to jointly negotiate wholesale prices for prescription drugs.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10